Tag Archive > Unstable Patients

Sanofi-aventis: Multaq(R) Approved in the European Union for Patients With Atrial Fibrillation

Paris, November 30 (ots/PRNewswire) – – First New Anti-Arrhythmic Drug to be Approved in the European Union in the Last 10 Years Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the European Commission has granted marketing authorization for Multaq(R) (dronedarone – 400mg Tablets) in all 27 European member states. This approval follows the European [...]

Continue reading

, , , , , , , , , , , , , , , , , ,